提升Biluochun茶活性提取物对CCl4诱导的急性肝损伤的改善作用
Xianrong Zhou1,2,3, Fei She4, Ruokun Yi1,2,3
1Collaborative Innovation Center for Child Nutrition and Health Development, Chongqing University of Education, Chongqing, 400067 China.
Food science and biotechnology
|July 14, 2025
概括
比卢茶提取物通过减少炎症和改善肝功能来保护四化碳诱导的肝损伤. 关键化合物如myricetin,quercetin和hesperetin可能有助于这些肝保护作用.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 比卢茶具有已知的抗氧化和抗炎性质.
- 比卢茶对肝脏疾病的影响以前没有被研究过.
研究的目的:
- 在急性肝损伤的小鼠模型上评估Biluochun生物活性提取物对肝脏的保护作用.
- 为了确定主要的生物活性成分,负责观察到的影响.
主要方法:
- 在五个实验小组中建立了碳四化物 (CCl4) 诱导的急性肝损伤小鼠模型.
- 血清生化标志物 (LDL-C,HDL-C,AST,ALT,AKP) 和细胞因子水平 (IL-1β,IL-6,IFN-γ,IL-10) 的评估.
- 在肝组织中使用定量实时PCR对关键炎症和亡基因 (NFκB-p65,IL-1β,IL-12,TNF-α,TGF-β,NOS,IL-10,IκB-α,Bcl-2,GSH) 的mRNA表达的分析.
- 使用高性能液态染色学 (HPLC) 对生物活性成分的定性分析.
主要成果:
- 蓝提取物显著改善了CCl4诱导的器官损伤.
- 血清中LDL-C,AST,ALT,AKP,IL-1β,IL-6和IFN-γ的水平下降,而HDL-C和IL-10的水平增加.
- 观察到NFκB-p65,IL-1β,IL-12,TNF-α,TGF-β和NOS mRNA表达的下调,以及IL-10,IκB-α,Bcl-2和GSH mRNA表达在肝脏组织中的上调.
- 在HPLC中确定了myricetin,quercetin和hesperetin作为提取物的主要成分.
结论:
- 比鲁茶的活性提取物显示出对CCl4诱导的急性肝损伤有显著的肝保护作用.
- 治疗机制可能与瑞,瑞和瑞在提取物中的抗氧化和抗炎活性有关.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...


